SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-066990
Filing Date
2018-11-08
Accepted
2018-11-08 16:31:30
Documents
50
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a18-19012_110q.htm 10-Q 1192323
2 EX-31.1 a18-19012_1ex31d1.htm EX-31.1 13253
3 EX-31.2 a18-19012_1ex31d2.htm EX-31.2 12843
4 EX-32.1 a18-19012_1ex32d1.htm EX-32.1 7071
5 EX-32.2 a18-19012_1ex32d2.htm EX-32.2 7059
  Complete submission text file 0001104659-18-066990.txt   5758885

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT loxo-20180930.xml EX-101.INS 1554556
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT loxo-20180930.xsd EX-101.SCH 40378
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT loxo-20180930_cal.xml EX-101.CAL 34671
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT loxo-20180930_def.xml EX-101.DEF 131823
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT loxo-20180930_lab.xml EX-101.LAB 350380
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT loxo-20180930_pre.xml EX-101.PRE 238637
Mailing Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901
Business Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901 203-653-3880
Loxo Oncology, Inc. (Filer) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36562 | Film No.: 181170122
SIC: 2834 Pharmaceutical Preparations